Be part of the knowledge - Global Oncology Academy

Medical News

Medical News
Dermatologists Working with Convolutional Neural Networks Showed Improvement in Melanoma Identification
hcplive.com
05/26/2023
Read more
Medical News
Burjeel Medical City Launches Advanced Gynecology Institute to Offer Complex Care Solutions for Women
businesswire.com
05/26/2023
Read more
Medical News
With a Focus on Clinical Research, Miami Cancer Institute’s Clinical Trials Benefit Patients
miamiherald.com
05/25/2023
Read more

See more news

Targeting HER3 in Breast and Lung Cancers: Where We Are and Where We Are Going
Targeting HER3 in Breast and Lung Cancers: Where We Are and Where We Are Going
CME/CE
Targeting HER3 in Breast and Lung Cancers: Where We Are and Where We Are Going
0.50 credits
- Jennifer Caudle, DO
  Peer
- Sara A. Hurvitz, MD, FACP
  Peer
- Narjust Florez, MD
  Peer
0.50 credits
Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
Project Oncology®
Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Megan Kruse, MD
  Peer
A Review of the Multiple Myeloma Treatment Journey
A Review of the Multiple Myeloma Treatment Journey
Project Oncology®
A Review of the Multiple Myeloma Treatment Journey
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Morie Gertz, MD, MACP
  Peer
- Aaron Rosenberg, MD, MS
  Peer
Better Early Than Late: CDK4/6 Inhibition in HR+, HER2- Early Breast Cancer
Better Early Than Late: CDK4/6 Inhibition in HR+, HER2- Early Breast Cancer
CME/CE
Better Early Than Late: CDK4/6 Inhibition in HR+, HER2- Early Breast Cancer
0.50 credits
- Hope S. Rugo, MD, FASCO
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
0.50 credits
The Role of GPRC5D in the Multiple Myeloma Treatment Paradigm
The Role of GPRC5D in the Multiple Myeloma Treatment Paradigm
Project Oncology®
The Role of GPRC5D in the Multiple Myeloma Treatment Paradigm
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Joshua Richter, MD
  Peer
Managing Multiple Myeloma Patients: Providing Better Care
Managing Multiple Myeloma Patients: Providing Better Care
Project Oncology®
Managing Multiple Myeloma Patients: Providing Better Care
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Noopur Raje, MD
  Peer
- Shaji K. Kumar, MD
  Peer

CME/CE

Addressing the Challenge in Rechallenge Strategies for mCRC
Addressing the Challenge in Rechallenge Strategies for mCRC
CME/CE
Addressing the Challenge in Rechallenge Strategies for mCRC
0.25 credits
- Fortunato Ciardiello, MD, PhD
  Peer
- Erika Martinelli, MD, PhD
  Peer
0.25 credits
What Is the Evidence Supporting HER2-Targeted TKI-Based Combination Regimens in Metastatic Colorectal Cancer?
What Is the Evidence Supporting HER2-Targeted TKI-Based Combination Regimens in Metastatic Colorectal Cancer?
Minute CME/CE™
What Is the Evidence Supporting HER2-Targeted TKI-Based Combination Regimens in Metastatic Colorectal Cancer?
1.00 program credit
- Andrea Cercek, MD
  Peer
1.00 program credit
Navigating New Waters in HER2+ mCRC: Selection of the Optimal Targeted Regimen, a Case-Based Approach
Navigating New Waters in HER2+ mCRC: Selection of the Optimal Targeted Regimen, a Case-Based Approach
Minute CME/CE™
Navigating New Waters in HER2+ mCRC: Selection of the Optimal Targeted Regimen, a Case-Based Approach
1.00 program credit
- John H. Strickler, MD
  Peer
1.00 program credit
A Look at HER2-Targeted TKIs: How Does Target Specificity Impact Outcomes?
A Look at HER2-Targeted TKIs: How Does Target Specificity Impact Outcomes?
Minute CME/CE™
A Look at HER2-Targeted TKIs: How Does Target Specificity Impact Outcomes?
1.00 program credit
- Andrea Cercek, MD
  Peer
1.00 program credit

Clinical Practice

A Changing Paradigm for Cancer Screening: Exploring Surrogate Endpoints for an Urgent Public Health Concern
A Changing Paradigm for Cancer Screening: Exploring Surrogate Endpoints for an Urgent Public Health Concern
Project Oncology®
A Changing Paradigm for Cancer Screening: Exploring Surrogate Endpoints for an Urgent Public Health Concern
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Eric Klein, MD
  Peer
Expert Insights on Multiple Myeloma Recognition & the Treatment Landscape
Expert Insights on Multiple Myeloma Recognition & the Treatment Landscape
Project Oncology®
Expert Insights on Multiple Myeloma Recognition & the Treatment Landscape
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Samer Al Hadidi, MD, MS, FACP
  Peer
Disease Spotlight: Multiple Myeloma
Disease Spotlight: Multiple Myeloma
Project Oncology®
Disease Spotlight: Multiple Myeloma
- Ruben Niesvizky, MD
  Peer
Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?
Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?
Project Oncology®
Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Hope S. Rugo, MD, FASCO
  Peer

Programs

Managing Immunotherapy Toxicities in Lung Cancer Patients
Managing Immunotherapy Toxicities in Lung Cancer Patients
Project Oncology®
Managing Immunotherapy Toxicities in Lung Cancer Patients
- Jacob Sands, MD
  Peer
- Aliyah Pabani, MD
  Peer
Expert Perspectives on Treating Relapsed or Refractory Multiple Myeloma
Expert Perspectives on Treating Relapsed or Refractory Multiple Myeloma
Project Oncology®
Expert Perspectives on Treating Relapsed or Refractory Multiple Myeloma
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Morie Gertz, MD, MACP
  Peer
- Ravi Vij, MD
  Peer
Expert Panel: Selection and Sequencing HER2-Targeted Therapies for mCRC
Expert Panel: Selection and Sequencing HER2-Targeted Therapies for mCRC
Minute CME/CE™
Expert Panel: Selection and Sequencing HER2-Targeted Therapies for mCRC
1.00 program credit
- John H. Strickler, MD
  Peer
- Andrea Cercek, MD
  Peer
1.00 program credit
Minute CME/CE™
Advancing the Standard of Care in HER2 Positive mCRC: The Role of Tyrosine Kinase Inhibitors
1.00 credit 7 episodes
- John H. Strickler, MD
  Peer
- Andrea Cercek, MD
  Peer
1.00 credit 7 episodes